A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP-activated protein kinase pathway

GY3 increases glucose consumption and decreases lipid ccumulation in HepG2 hepatocytes and mature 3T3-L1 adipocytes through AMPK pathway. Control (CL), Metformine (Met), Rosiglitazone (Ros).232